Encompass Health Corporation $EHC Stock Position Reduced by Copeland Capital Management LLC

Copeland Capital Management LLC lessened its holdings in Encompass Health Corporation (NYSE:EHC) by 5.2% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 764,703 shares of the company’s stock after selling 41,839 shares during the quarter. Encompass Health makes up approximately 1.8% of Copeland Capital Management LLC’s holdings, making the stock its 4th largest position. Copeland Capital Management LLC’s holdings in Encompass Health were worth $81,166,000 at the end of the most recent quarter.

Several other large investors have also recently bought and sold shares of EHC. Millennium Management LLC increased its holdings in Encompass Health by 140.0% in the third quarter. Millennium Management LLC now owns 1,223,665 shares of the company’s stock valued at $155,430,000 after buying an additional 713,738 shares during the last quarter. 8 Knots Management LLC purchased a new position in shares of Encompass Health during the second quarter worth about $78,644,000. Alliancebernstein L.P. grew its holdings in shares of Encompass Health by 23.4% during the third quarter. Alliancebernstein L.P. now owns 2,515,878 shares of the company’s stock worth $319,567,000 after purchasing an additional 476,564 shares during the last quarter. Thrivent Financial for Lutherans grew its holdings in shares of Encompass Health by 57.8% during the third quarter. Thrivent Financial for Lutherans now owns 1,194,859 shares of the company’s stock worth $151,544,000 after purchasing an additional 437,464 shares during the last quarter. Finally, Raymond James Financial Inc. grew its holdings in shares of Encompass Health by 34.8% during the third quarter. Raymond James Financial Inc. now owns 1,541,336 shares of the company’s stock worth $195,780,000 after purchasing an additional 397,694 shares during the last quarter. Hedge funds and other institutional investors own 97.25% of the company’s stock.

Encompass Health Stock Performance

Shares of EHC stock opened at $101.95 on Friday. Encompass Health Corporation has a 1 year low of $92.77 and a 1 year high of $127.99. The firm has a market cap of $10.14 billion, a price-to-earnings ratio of 18.40, a PEG ratio of 1.96 and a beta of 0.75. The stock’s 50-day moving average is $103.82 and its two-hundred day moving average is $108.42. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.08 and a current ratio of 1.08.

Encompass Health (NYSE:EHC) last announced its earnings results on Thursday, February 5th. The company reported $1.46 earnings per share for the quarter, topping the consensus estimate of $1.29 by $0.17. Encompass Health had a net margin of 9.54% and a return on equity of 18.20%. The business had revenue of $3.09 billion during the quarter, compared to the consensus estimate of $1.54 billion. During the same quarter in the prior year, the firm earned $1.17 earnings per share. The business’s quarterly revenue was up 9.9% compared to the same quarter last year. Encompass Health has set its FY 2026 guidance at 5.810-6.100 EPS. Analysts predict that Encompass Health Corporation will post 5.91 earnings per share for the current year.

Encompass Health Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Wednesday, April 15th. Stockholders of record on Wednesday, April 1st were paid a dividend of $0.19 per share. The ex-dividend date was Wednesday, April 1st. This represents a $0.76 annualized dividend and a dividend yield of 0.7%. Encompass Health’s dividend payout ratio is 13.72%.

Wall Street Analysts Forecast Growth

Several equities analysts have issued reports on the company. Wall Street Zen lowered Encompass Health from a “buy” rating to a “hold” rating in a report on Saturday, April 11th. Barclays raised their price objective on Encompass Health from $150.00 to $153.00 and gave the stock an “overweight” rating in a report on Friday, February 6th. Two equities research analysts have rated the stock with a Strong Buy rating, seven have issued a Buy rating and one has assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Buy” and a consensus price target of $143.29.

Insider Activity

In other news, CEO Mark J. Tarr sold 150,000 shares of the stock in a transaction dated Wednesday, February 11th. The shares were sold at an average price of $111.64, for a total transaction of $16,746,000.00. Following the completion of the sale, the chief executive officer owned 377,070 shares in the company, valued at approximately $42,096,094.80. This represents a 28.46% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Treasurer Edmund Fay sold 11,937 shares of the firm’s stock in a transaction dated Monday, March 9th. The shares were sold at an average price of $107.00, for a total transaction of $1,277,259.00. Following the completion of the sale, the treasurer owned 89,325 shares of the company’s stock, valued at approximately $9,557,775. The trade was a 11.79% decrease in their position. The disclosure for this sale is available in the SEC filing. 1.80% of the stock is currently owned by corporate insiders.

About Encompass Health

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.